Murray Cod Australia raises $10.1M to turn fish into cash
What's the deal? Murray Cod AustraliaDealroom has a profile for this one. Try Dealroom → (ASX: MCA) has completed the institutional leg of a $18.6M capital raise, pulling in $10.1M by issuing roughly 67.2 million new shares at $0.15 each. The institutional take-up rate hit about 67.59%.
The broader offer is a 1-for-1 fully underwritten accelerated non-renounceable entitlement offer. The retail component opens on May 8 and closes on May 20.
Why now? The company needs cash to convert 3,700 tonnes of saleable fish biomass into revenue. About $15.9M of the proceeds is earmarked for working capital to do exactly that, with $800K set aside for expanding processing capacity and product formats.
New chief executive officer Steven Chaur is driving a refreshed strategy focused on a customer-led, multi-channel domestic sales approach. Another $400K goes toward restructuring costs, and $1.5M covers the cost of the offer itself.
What could go wrong? Dilution is the big concern. The offer will result in roughly 123.9 million new shares — about 50% of the company's post-completion total. Because the rights are non-renounceable, shareholders who don't participate can't trade their rights and will see their stakes diluted.
Control dynamics are also shifting. Major shareholder Regal Funds ManagementDealroom has a profile for this one. Try Dealroom → and chair Brett Paton have each committed to taking up their full institutional entitlements and sub-underwriting up to $4M apiece. That could push Regal's voting power to 27.03% and Paton's to 15.45%, depending on overall take-up and shortfall outcomes.
The signal: Murray Cod Australia, classified as an early growth company on Dealroom, is essentially asking investors to fund the bridge between biology and commerce — converting pond-grown biomass into packaged product at scale. With Regal Funds Management, an established investment fund, committing to its full entitlement and sub-underwriting up to $4M, there's a notable concentration of conviction from institutional backers even as the 50% dilution raises the stakes for smaller shareholders.
Read more: smallcaps.com.au
